Technology
Our new and innovative chromatographic immunoassay technology called Dual Path Platform (DPP®) is ideal for rapid, point-of-care diagnostic testing of a wide variety of analytes.
Patents
10 U.S. Patents Issued, 14 U.S. Patent Applications, 11 International Patents Issued, 6 International Patents Pending
Publications
Find a list of journal articles referencing our point-of-care tests and technology.
